The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy

Pediatric Nephrology

Volumn 13, Issue 7, 1999, Pages 564-566

  Burke, Gladstone A A ^a   McGraw, Mary E ^a   MacIver, Angus G ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Cyclosporin; Renal transplant; Thrombotic microangiopathy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; TACROLIMUS;

ADOLESCENT; ARTICLE; CASE REPORT; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; BIOPSY; CAPILLARIES; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY GLOMERULUS; RETREATMENT; TACROLIMUS; THROMBOSIS;

EID: 0032805585     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050743     Document Type: Article

References (9)

1. Hochstetler LA, Flanigan MJ, Lager DJ (1994) Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy. Am J Kidney Dis 23:444-450
2. Zent R, Katz A, Quaggin S, Cattran D, Wade J, Cardella C, Zaltzman, Fenton S, Cole E (1997) Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A. Clin Nephrol 47:181-186
3. Wiener Y, Nakhleh RE, Lee MW, Escobar FS, Venkat KK, Kupin WL, Mozes MF (1997) Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Clin Transplant 11:157-162
4. McCauley J, Bronsther O, Fung J, Todo S, Starzl T (1989) Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 11:1516
5. Richardson D, Jones CH, Newstead CG, Will EJ, Lodge JP (1996) The successful conversion to tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic uraemic syndrome. Nephrol Dial Transplant 11:2498-2500
6. Schmidt RJ, Venkat KK, Dumler F (1991) Hemolytic-rremic syndrome in a renal transplant recipient on FK506 immuno-suppression. Transplant Proc 23:3156-3157
7. Morozumi K, Sugito K, Oda A, Takeuchi O, Fukuda M, Usami T, Oikawa T, Fujinami T, Koyama K, Takeda A, Yoshida A, Haba T, Tominaga Y, Uchida K, Yokoyama I, Takagi H (1996) A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? Transplant Proc 28:1076-1078
8. Grupp C, Schmidt F, Braun F, Lorf T, Ringe B, Müller GA (1998) Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation - is tacrolimus the answer? Nephrol Dial Transplant 13:1629-1631
9. Kiss D, Landmann J, Mihatsch M, Huser B, Brunner FP, Thiel G (1992) Risks and benefits of graft biopsy in renal transplantation under cyclosporin-A. Clin Nephrol 38:132-134